Sunday, January 05, 2025 10:08:53 PM
Science and potential alone does nothing if it’s not accompanied by relentless and smart execution. There are multiple therapies that get published in top tier journal but quite a few of them fail in the end due to bad execution and missteps from management.
This crew has lied again and again to shareholders. That alone should give anyone a pause. Once a liar always a liar.
4 plus years from data lock and no application to any other jurisdictions outside the UK is another joke. They didn’t even submit reimbursement evidence in the UK. Even a company of half a dozen people with much less funding than NWBO has had in the last 4 years would have done 2 to 3 X better.
It’s of course up to you when you want to exit, but if you plan to stick around post UK approval, at least look for signs around financial support from big pharma. If there is no upfront cash and financial backing from big pharma, I’d get out right away and not look back regardless of what BS anyone tries to sell. It would be a death spiral and shorts will certainly slam this to ground again. Try to preserve whatever capital you have left and don’t live in denial at that point!
This crew has lied again and again to shareholders. That alone should give anyone a pause. Once a liar always a liar.
4 plus years from data lock and no application to any other jurisdictions outside the UK is another joke. They didn’t even submit reimbursement evidence in the UK. Even a company of half a dozen people with much less funding than NWBO has had in the last 4 years would have done 2 to 3 X better.
It’s of course up to you when you want to exit, but if you plan to stick around post UK approval, at least look for signs around financial support from big pharma. If there is no upfront cash and financial backing from big pharma, I’d get out right away and not look back regardless of what BS anyone tries to sell. It would be a death spiral and shorts will certainly slam this to ground again. Try to preserve whatever capital you have left and don’t live in denial at that point!
Recent NWBO News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
